Dexlansoprazole INN

Composition : Dsec-30 : Each Capsule Contains Dexlansoprazole INN 30mg as enteric coated granules.

Dsec-60 : Each Capsule Contains Dexlansoprazole INN 60mg as enteric coated granules.

Indications : Dexlansoprazole is indicated for-

• Healing of Erosive Esophagitis (EE).

• Maintenance of Healed Erosive Esophagitis.

• Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD).

Dosage and administration : Dexlansoprazole dosing recommendations:


Recommended Dose


Healing of EE

60 mg

Once daily for up to 8 weeks

Maintenance of Healed EE

30 mg

Once daily

Symptomatic Non-Erosive GERD

30 mg

Once daily for 4 weeks

• Dexlansoprazole can be taken with or without food.

• This capsules should be swallowed whole; Should not be chewed.

• Alternatively, capsules can be administered as follows:

- Open capsule.

- Sprinkle intact granules on 1 table spoon.

- Swallow immediately. Granules should not be chewed. Or, as directed by the registered physicians.

Use in pregnancy and lactation : Pregnancy Category B. There are no adequate and well-controlled studies in pregnant women. It is not known whether dexlansoprazole is excreted in human milk.

Packing : Dsec-30 : Each box contains 30 capsules in alu-alu blister pack.

Dsec-60 : Each box contains 28 capsules in alu-alu blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.